R R Holman

Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29.

R. Holman, I. Stratton, R. Turner, 1999, Archives of internal medicine.

Randomized controlled pilot trial of a hand-held patient-oriented, insulin regimen optimizer.

R. Holman, J. Nealon, R R Holman, 1996, Medical informatics = Medecine et informatique.

Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentrations.

T D Hockaday, R. Holman, R. Turner, 1979, Metabolism: clinical and experimental.

United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors.

Stephen J. Aldington, E M Kohner, R. Holman, 1998, Archives of ophthalmology.

Approach to maintaining comparability of biochemical data during long-term clinical trials.

R. Holman, I. Stratton, R. Turner, 1997, Clinical chemistry.

Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.

A Gray, A. Farmer, R. Holman, 2009, Health technology assessment.

The impact of diabetes‐related complications on healthcare costs: new results from the UKPDS (UKPDS 84)

A Gray, R. Holman, A. Gray, 2015, Diabetic medicine : a journal of the British Diabetic Association.

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

R. Holman, R. Turner, C. Cull, 1999, JAMA.